Debilitating long COVID pain and POTS, somewhat better with low-dose naltrexone and salt
- Condition
- Long COVID
- At worst
- Moderate (mostly housebound)
- Ill before improving or writing
- Not stated
- Last post
- Oct 2026
In their words
- Condition: Long COVID
my particular case of chronic illness goes back a long way, but became exacerbated greatly following a number of COVID infections and exposures
In context ↗ - At worst: Moderate
These symptoms reached the level of debilitating about a year ago
In context ↗ - Now: Somewhat better
Dr. Rany Condos and Jenny Luie were the first people to actually help me after two unbelievably horrifying years during which I saw upwards of 30 doctors
In context ↗ - Began after: COVID
became exacerbated greatly following a number of COVID infections and exposures
Read from 8 of their posts and comments; links to the 6 this page draws on
Summary
Starling 54685's periodic breathlessness, chest pain and dizziness worsened greatly after several COVID infections, bringing hyperadrenergic POTS, severe abdominal pain and nerve pain to a debilitating level around 2024. Low-dose naltrexone, ramped from 0.5 mg to about 4.2 mg over a year, is what they credit most, with salt second. A pharmacy error cut their dose to a quarter, causing over a month of severe pain.
Ask Miruvor AI
What they tried
What they credit
Also tried
Their words about each treatment
- Clonazepam · Helped
However, I get terrible rebound from the smallest dose, even after taking it for only a day or two.
In context ↗ - beta blockers · Worse
having had some success with MCAS-oriented treatments, but bad reactions to beta blockers
In context ↗ - an SSRI · Worse
having had bad experiences with an SSRI in the past, particularly with the withdrawal from it
In context ↗ - low-dose naltrexone · Helped a lot
I was prescribed low-dose naltrexone. That is the one med I absolutley know helped.
In context ↗ - salt · Helped
Second to this was perhaps the salt, which I struggled to wrap my head around having so much of for a while before finally doing it.
In context ↗ - pyridostigmine · No change
I have not had success with pyridostigmine
In context ↗ - vagal nerve stimulation excercises · No change
I have not had success with pyridostigmine, vagal nerve stimulation excercises, or choline supplementation
In context ↗
Approaches: POTS medication
Their path
How ill they were on the ME/CFS severity scale, estimated from what they describe at each point, in the order they describe; they don’t give enough times to place each step. Hover or tap a point. Dates are when they posted. What the levels mean.
Show as a table
| When | What happened | Where they were | After |
|---|---|---|---|
| — | periodic breathlessness, chest pain, dizziness and fast heart rate before COVIDPrior to COVID, I had periodic episodes of shortness of breath, chest pain, elevated heart rate, and dizziness. These were very troubling, but manageableIn context ↗ | Mild | |
| about a year before May 2025 | after several COVID infections symptoms became far worse and reached a debilitating levelThese symptoms reached the level of debilitating about a year agoIn context ↗ | Moderate | |
| 2025 | low-dose naltrexone started to work while titrating upI felt like it started to work around 1.5mg and after about a month or so, and became more pronounced as I climbed.In context ↗ | Moderate | Low-dose naltrexone |
| 2025 | compounding pharmacy dispensed a quarter of the dose, symptoms returnedI unintentionally stepped down to 0.65mg and after a week started feeling terrible symptomsIn context ↗ | Moderate | |
| 2026-10-04 | ramped back up to about 4.2 mg low-dose naltrexone, which they credit most; salt secondIt took about a year for me to ramp up from 0.5mg to around 4.2mg. Second to this was perhaps the saltIn context ↗ | Moderate | Low-dose naltrexone |
Adverse events
- Clonazepam (Klonopin)“I get terrible rebound from the smallest dose, even after taking it for only a day or two. The few times I have taken it for a couple months, it's taken weeks to taper off a 0.25mg.” In context ↗ Withdrawal problems
- Beta-blockers (unspecified)“having had some success with MCAS-oriented treatments, but bad reactions to beta blockers” In context ↗ Side effects
- Antidepressants (unspecified)“having had bad experiences with an SSRI in the past, particularly with the withdrawal from it” In context ↗ Withdrawal problems
Symptoms mentioned
Their words about their symptoms
- POTS & dysautonomia
hyperadrenergic POTS, clinically diagnosed via a tilt table test
In context ↗ - Mast cell (MCAS) & allergies
I have what is almost certainly MCAS
In context ↗ - Pain & fibromyalgia
episodes of body aching
In context ↗ - Neuropathy & tingling
shooting nerve pain, cranial neuralgia
In context ↗ - Heart symptoms & palpitations
painful ectopic beats, tachycardic episodes
In context ↗ - Gut problems
severe abdominal pain
In context ↗ - Breathlessness
periodic episodes of shortness of breath
In context ↗ - Anxiety & low mood
I definitely get a lot of depression and emotional pain flooding in
In context ↗
Ask Miruvor AI
Similar stories
-
Mostly housebound with ME/CFS, now a little better on Klonopin and low-dose naltrexone
Joseph, 47, in Los Angeles, developed ME/CFS in January 2024, about 18 days after a second COVID infection. He declined from mild to the bad end of moderate over six months, becoming mostly housebound. Klonopin, low-dose naltrexone, midodrine and propranolol…
-
Bedbound with ME/CFS for over a year, now partly better with pacing and LDN
A Dutch long-hauler became ill with COVID in mid-2022 and was bedbound, in bed around the clock, for over a year. Rest and pacing, a 75% vegetable diet that fixed their gut, NAC for brain fog, LDN for PEM and ivabradine for POTS brought slow, partial gains.…
-
ME/CFS with daily PEM, headaches and POTS, somewhat better with LDN and Emgality
Bramble 24296 has ME/CFS after long COVID, with daily PEM, flu-like symptoms, constant headaches and POTS. Low-dose naltrexone, started for long-COVID fatigue, eased fatigue a little and stopped her catching every cold. Calcium channel blockers, salt and…
-
wabi-sabi on Phoenix Rising
wabi-sabi fell ill after a viral infection in May 2014, stayed mild until an exercise crash in 2018 made her moderate, and declined to very severe by 2022. Mestinon and later mast cell drugs (cromolyn, ketotifen, xolair, LDN) improved her; a COVID infection…